IDT vs iQSTEL
IDT and IQST side by side, both in telephone communications. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How IDT and IQST compare
IDT is the larger company, worth 7.0 times as much as iQSTEL ($1.9B against $278M).
iQSTEL grew revenue faster over the last twelve months (39.3% versus 5.4% for IDT).
IDT keeps more of each dollar of sales as profit, with a net margin of 6.7% compared with −2.2% at iQSTEL.
IDT pays a dividend yielding 0.35%; iQSTEL does not pay one.
IDT scores higher on the StockData Score (18 against 6 for iQSTEL), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | IDT | IQST |
|---|---|---|
| Size and price | ||
| Market cap | $1.9B | $278M |
| Share price | $77.86 | $0.690 |
| Change, 1 year | 50.5% | −86.6% |
| Change, 5 years | 33.1% | −98.3% |
| Beta (5Y) | 0.36 | 0.97 |
| Employees | 1,971 | 100 |
| StockData Score | ||
| Total score | 18 (better) | 6 |
| Valuation score | 0 | 0 |
| Growth score | 4 (better) | 2 |
| Performance score | 5 (better) | 1 |
| Health score | 6 (better) | 3 |
| Dividend score | 3 (better) | 0 |
| Valuation | ||
| P/E | 22.5× | – |
| P/S | 1.5× | 0.7× (better) |
| P/B | 5.1× (better) | 16.2× |
| EV/EBITDA | 12.1× | – |
| P/FCF | 28.5× | – |
| PEG | 0.75 | – |
| FCF yield | 3.5% (better) | −1.4% |
| Fair value | $53.65 | – |
| Margin of safety | −45.1% | – |
| Growth | ||
| Revenue growth (TTM) | 5.4% | 39.3% (better) |
| Revenue growth, 5Y average | −2.2% | 37.4% (better) |
| Net income growth (TTM) | 13.9% | – |
| EPS growth (TTM) | 15.0% | – |
| EPS growth, 5Y average | −1.3% | – |
| Profitability | ||
| Gross margin | 38.3% (better) | 2.7% |
| Operating margin | 9.3% (better) | −1.3% |
| Net margin | 6.7% (better) | −2.2% |
| FCF margin | 5.2% (better) | −0.99% |
| Return on equity | 25.4% (better) | −56.0% |
| Return on invested capital | 75.4% (better) | −23.3% |
| Financial health | ||
| Debt / equity | 0.00 | 0.15 (better) |
| Current ratio | 1.86 (better) | 1.09 |
| Altman Z-score | 6.39 | 11.90 (better) |
| Piotroski F-score | 6 (better) | 3 |
| Dividends and buybacks | ||
| Dividend yield | 0.35% | – |
| Payout ratio | 7.5% | – |
| Years of dividend growth | 2 | – |
| Shareholder yield | 0.35% (better) | 0.00% |
| Ownership | ||
| Held by institutions | 56.5% | 0.06% |
| Held by insiders | 17.6% | 0.00% |
| Insider net buying, 12 months | −$7.7M | – |
| Short interest, % of float | 4.9% | 0.10% |
Go deeper
- IDT stock overview
- IDT income statement
- IDT valuation and score
- IQST stock overview
- IQST income statement
- IQST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.